Literature DB >> 30912042

Production and Validation of Lentiviral Vectors for CRISPR/Cas9 Delivery.

Laura Barrett Ryø1, Emil Aagaard Thomsen1, Jacob Giehm Mikkelsen2.   

Abstract

Genetic information transferred by HIV-1-based lentiviral vectors as single-stranded RNA is converted to double-stranded DNA by reverse transcription and subsequently inserted into the genome of recipient cells. Integration into the genome allows stable, long-term expression of genes-of-interest driven by promoter sequences contained within the vector. This technology can be used as a standard method for production of cells stably expressing Cas9 protein and single guide RNA (sgRNA), the key components of the CRISPR genome editing system. Here, we provide a protocol for production and validation of VSV-G-pseudotyped lentiviral vectors for delivery of the CRISPR system and generation of knockout cell lines.

Entities:  

Keywords:  CRISPR/Cas9; Forward genetics; Genome-wide screening; Lentiviral; sgRNA

Mesh:

Substances:

Year:  2019        PMID: 30912042     DOI: 10.1007/978-1-4939-9170-9_7

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  A genome-wide CRISPR-Cas9 knockout screen identifies novel PARP inhibitor resistance genes in prostate cancer.

Authors:  Malene Blond Ipsen; Ea Marie Givskov Sørensen; Emil Aagaard Thomsen; Simone Weiss; Jakob Haldrup; Anders Dalby; Johan Palmfeldt; Peter Bross; Martin Rasmussen; Jacob Fredsøe; Søren Klingenberg; Mads R Jochumsen; Kirsten Bouchelouche; Benedicte Parm Ulhøi; Michael Borre; Jacob Giehm Mikkelsen; Karina Dalsgaard Sørensen
Journal:  Oncogene       Date:  2022-08-06       Impact factor: 8.756

2.  Research Techniques Made Simple: Delivery of the CRISPR/Cas9 Components into Epidermal Cells.

Authors:  Huishan Shi; Jos P H Smits; Ellen H van den Bogaard; Matthew G Brewer
Journal:  J Invest Dermatol       Date:  2021-06       Impact factor: 7.590

3.  Identification of BLNK and BTK as mediators of rituximab-induced programmed cell death by CRISPR screens in GCB-subtype diffuse large B-cell lymphoma.

Authors:  Emil Aagaard Thomsen; Anne Bruun Rovsing; Mads Valdemar Anderson; Hanne Due; Jinrong Huang; Yonglun Luo; Karen Dybkaer; Jacob Giehm Mikkelsen
Journal:  Mol Oncol       Date:  2020-07-16       Impact factor: 6.603

4.  CRISPR-Cas9-directed gene tagging using a single integrase-defective lentiviral vector carrying a transposase-based Cas9 off switch.

Authors:  Emil Aagaard Thomsen; Kristian Alsbjerg Skipper; Sofie Andersen; Didde Haslund; Thomas Wisbech Skov; Jacob Giehm Mikkelsen
Journal:  Mol Ther Nucleic Acids       Date:  2022-08-04       Impact factor: 10.183

Review 5.  Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years.

Authors:  Jonas Holst Wolff; Jacob Giehm Mikkelsen
Journal:  J Biomed Sci       Date:  2022-10-09       Impact factor: 12.771

6.  Single-Cell Monitoring of Activated Innate Immune Signaling by a d2eGFP-Based Reporter Mimicking Time-Restricted Activation of IFNB1 Expression.

Authors:  Emil Aagaard Thomsen; Sofie Andersen; Mikkel Haarslev Schröder Marqvorsen; Kristian Alsbjerg Skipper; Søren R Paludan; Jacob Giehm Mikkelsen
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.